Stock Market & Financial Investment News

News Breaks July 17, 2012 10:53 EDT ABT Earnings Preview: Abbott trading near 52-week high ahead of Q2 earnings Abbott (ABT) is expected to report Q2 earnings before the market open on Wednesday, July 18 with a conference call scheduled for 9:00 am ET. Analysts are looking for EPS of $1.22 on revenue of $9.84B. The consensus range is $1.20-$1.23 for EPS, and $9.68B-$10.04B for revenue, according to First Call. After reporiting better-than-expected EPS and revenue in Q1, the company gave a full-year EPS guidance of $5.00-$5.10, and said it expects the split into two publicly traded companies to be completed by the end of the year. Investors will look for further updates on the planned split and its timeline. In the previous quarter, Abbott received FDA approval for its Healon EndoCoat gel and FDA clearance for iFS Advanced Femtosecond Laser. It also had positive clinical results for hepatitus C treatment and rheumatoid arthritis treatment. Earlier in the quarter, RBC Capital said Abbott shares should be bought on weakness. The majority of analysts have maintained the company at Hold. News For ABT From The Last 14 Days Check below for free stories on ABT the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. June 19, 2013 08:45 EDT ABT Leerink's biotech analyst holds analyst/industry conference call on ADA Analyst Antlaffy, along with Dr. George Grunberger, founder & Chairman of the Grunberger Diabetes Institute, preview the upcoming American Diabetes Association's conference, including perspectives on new devices in diabetes, potential disruptive technologies at ADA and progress towards the artificial pancreas on an Analyst/Industry conference call to be held on June 20 at 2 pm. June 18, 2013 07:28 EDT ABT Wells Faro to host a conference Subscribe for More Information June 14, 2013 12:23 EDT ABT Abbott announces new $3B share repurchase plan Subscribe for More Information 12:23 EDT ABT Abbott announces new $3B share repurchase plan June 13, 2013 11:02 EDT ABT Leerink's major pharma analyst holds an analyst/Industry conference call Subscribe for More Information June 11, 2013 09:33 EDT ABT Abbott begins Absorb BVS clinical trial in Japan Subscribe for More Information June 6, 2013 08:03 EDT ABT Abbott shares compelling, says Wells Fargo Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.